Gene: KCNJ18
Official Full Name: potassium inwardly rectifying channel subfamily J member 18provided by HGNC
Gene Summary: This gene encodes a member of the inwardly rectifying potassium channel family. Transcription of this locus is regulated by thyroid hormone, and the encoded protein plays a role in resting membrane potential maintenance. Mutations in this locus have been associated with thyrotoxic hypokalemic periodic paralysis. [provided by RefSeq, Jan 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16829 | KCNJ18 Knockout cell line (HeLa) | Human | KCNJ18 | 1:3~1:6 | Negative | Online Inquiry |
KCNJ18 Gene Knockout Cell Lines are specifically engineered cellular models that lack the KCNJ18 gene, which encodes for the potassium ion channel protein KCNJ18, known for its role in regulating cardiac and neuronal excitability. These knockout cell lines allow researchers to investigate the molecular underpinnings and physiological effects associated with KCNJ18 deficiency, granting profound insights into both normal cellular function and various pathophysiological conditions.
The primary mechanism by which these knockout cell lines operate involves the loss of KCNJ18-mediated potassium ion transport, leading to altered membrane potential and ion homeostasis in the affected cells. Researchers can explore how the absence of KCNJ18 influences cellular responses, signal transduction, and the overall functioning of muscle and neuronal tissues. Understanding these pathways is critical for elucidating the gene’s role in diseases such as cardiac arrhythmias and certain types of epilepsy.
Scientifically, KCNJ18 Gene Knockout Cell Lines serve as invaluable tools in both academic and clinical research, enabling the study of gene function, drug interactions, and disease mechanisms. They offer essential platforms for pharmacological testing and therapeutic evaluations, paving the way for the identification of potential treatment strategies targeting conditions related to potassium channel dysfunction.
Compared to traditional cell lines, our KCNJ18 Gene Knockout Cell Lines provide a unique advantage by delivering specifically targeted insights into the gene’s role under controlled experimental conditions. Their specificity allows for clear analysis of gene function without the confounding effects of gene expression variability seen in non-knockout models.
For researchers and clinicians focused on cardiac and neurological health, these cell lines represent a critical advancement in elucidating the complexities of ion channel biology. Our commitment to high-quality, precision-engineered biological products stems from our extensive expertise in cellular biology and genetics, ensuring our customers receive the most reliable and cutting-edge tools necessary for advancing their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.